Younger Patients Who Survive Non-Hodgkin Lymphoma Face Higher Risk of Comorbidities
Researchers sought to determine the risk of comorbidities in younger patients who survive NHL compared with older patients.
Researchers sought to determine the risk of comorbidities in younger patients who survive NHL compared with older patients.
Researchers sought to determine whether CK1-alpha would be a viable target in patients with mantle cell lymphoma.
Researchers sought to determine whether prophylactic tocilizumab prior to anti-CD19 CAR-T therapy would be feasible for patients with NHL.
Researchers sought to determine whether CAR-T therapy would have better long-term clinical outcomes in patients with LBCL compared with salvage therapy.
Researchers sought to determine whether zanubrutinib would have a positive response in patients with relapsed/refractory marginal zone lymphoma.
A single-institution study determined the effect of a novel nursing practice on incidence of PICC-UEDVT, outcomes, and satisfaction with care in patients with NHL.
Researchers sought to determine whether patients with B-NHL who had treatment with anti-CD20 antibodies had an impaired serological response to an mRNA COVID-19 vaccine.
Researchers sough to assess the relationship between CD4/CD8 ratios and the risk for Kaposi sarcoma and non-Hodgkin lymphoma among patients with HIV infection treated with combination antiretroviral therapy.
Researchers sought to determine whether orelabrutinib and MIL62 combination therapy would be safe and effective in patients with relapsed/refractory NHL.
Researchers sought to determine whether glofitamab monotherapy would have high preliminary response rates in patients with R/R non-Hodgkin lymphoma.